JS Pascoe, D Palmer, D Spooner, DW Rea, SA Hussain (2009) 'Genomics and pharmacogenomics in the management of breast cancer'. Current Pharmacogenomics 6 45-55
SA Hussain, D Palmer, DE Swinson, P Riley, A Wills, C Brown, C Draycott, A El-Modir, DR Peake, DW Rea, AD Chetiyawardana, MH Cullen (2008) 'A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting'. Oncology reports 20 233-7
SA Hussain, DW Rea, D Palmer (2007) 'Reply: Randomised studies with translational end points are required to further elucidate the prognostic and predictive value of CA IX'. British Journal of Cancer 96 1310-1310
SA Hussain, R Ganesan, GM Reynolds, L Gross, AJ Stevens, J Pastorek, PG Murray, B Perunovic, LJ Billingham, ND James, D Spooner, CJ Poole, DW Rea, D Palmer (2007) 'Hypoxia regulated Carbonic Anhydrase IX expression is associated with poor survival in patients with invasive breast cancer'. British Journal of Cancer 96 104-109
HC Routledge, DW Rea, RP Steeds (2007) 'Monitoring of cardiotoxicity during immunotherapy with Herceptin using simultaneous continuous wave Doppler depending on N-terminal pro-brain natriuretic peptide - In response'. Clinical medicine (London, England) 7 89-89
SA Hussain, D Palmer, D Spooner, DW Rea (2007) 'Molecularly targeted therapeutics for breast cancer'. BioDrugs 21 215-224
SA Hussain, DW Rea, ND James, D Palmer (2007) 'Signal transduction therapy: Challenges to Clinical Trial Design'. Current Signal Transduction Therapy 2 21-30
CJ Poole, HM Earl, L Hiller, JA Dunn, S Bathers, RJ Grieve, D Spooner, RK Agrawal, IN Fernando, AM Brunt, SM O'Reilly, SM Crawford, DW Rea, P Simmonds, JL Mansi, A Stanley, PG Harvey, K McAdam, L Foster, RCF Leonard, CJ Twelves (2006) 'Epirubicin and cyclophosphamide, methotrexate and fluorouracil as adjuvant therapy for early breast cancer'. The New England Journal of Medicine 355 1851-1862
D Routledge, DW Rea, RP Steeds (2006) 'Monitoring the introduction of new drugs: Herceptin and cardiotoxicity'. Clinical Medicine 6 478-481
MH Cullen, NM Steven, LJ Billingham, CH Gaunt, M Hastings, P Simmonds, N Stuart, DW Rea, M Bower, IN Fernando, R Huddart, S Gollins (2005) 'Antibacterial prophylaxis after chemotherapy for solid tumours and lymphomas'. The New England Journal of Medicine 353 988-998
SA Hussain, D Palmer, A Stevens, D Spooner, CJ Poole, DW Rea (2005) 'Role of chemotherapy in breast cancer'. Expert Reviews on Anticancer Therapy 5 1095-1110
SA Hussain, D Palmer, S Moon, DW Rea (2004) 'Endocrine therapy and other targeted therapies for metastatic breast cancer'. Expert Review of Anticancer Therapy 4 1-17
SA Hussain, S Williams, A Stevens, DW Rea (2004) 'Endocrine therapy for early breast cancer'. Expert Review of Anticancer Therapy 4 877-888
DW Rea, L Hiller, HM Earl, JA Dunn, S Bathers, D Spooner, RK Agrawal (2004) 'Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: a non-radnomised comparison of patients treated in the NEAT trial'. Proceedings of the American Society of Clinical Oncology 23 595
G Caine, PS Stonelake, DW Rea, GYH Lip (2003) 'Coagulopathic complications in breast cancer'. Cancer 98 1578-1586
CJ Kirk, RM Harris, DM Wood, L Bottomley, DW Rea, PJ Hughes, RH Waring (2002) 'Environmental oestrogens: their role in testicular dysgenesis and hormone-dependent cancers'. Comparative Biochemistry & Physiology 132 S2
CJ Kirk, RM Harris, DM Wood, PJ Hughes, D Anderson, DW Rea, RH Waring (2001) 'Dietary phytoestrogens influence susceptibility to breast cancer by inhibiting sulphotransferase enzymes?' HEALFO Conference 'Food and Nutrition for Better Health, Lanciano, Italy 82
View all publications in research portal